Class ITerminated in FDA datasetFeb 13, 2026

Rosabella brand MORINGA; DIETARY SUPPLEMENT CAPSULES; 60 capsules per bottle

Recalling firm: Ambrosia Brands LLC

Why it was recalled

Product may be contaminated with Salmonella

Check the codes ↓

The exact product

Rosabella brand MORINGA; DIETARY SUPPLEMENT CAPSULES; 60 capsules per bottle; Distributed by: Ambrosia Brands, LLC, 625 Randall Ave, St. 100, Cheyenne, WY 82001; SUGGESTED USE: As a dietary supplement, take two (2) veggie capsules once a day. For best results, take 20-30 min before a meal with an 8oz. glass of water or as directed by your health professional; UPC: 8 60012 16172 0

Check the codes

Compare these FDA-provided codes, lot numbers or dates with the product you have.

Match the product, size and code together. A similar name alone does not identify your batch.

Original FDA code information

Lot # - Expiration Date: 5020591 - 03/2027 5020592 - 03/2027 5020593 - 03/2027 5020594 - 03/2027 5020595 - 03/2027 5020596 - 03/2027 5030246 - 04/2027 5030247 - 04/2027 5030248 - 04/2027 5030249 - 04/2027 5030250 - 04/2027 5030251 - 04/2027 5040270 - 05/2027 5040271 - 05/2027 5040272 - 05/2027 5040273 - 05/2027 5040274 - 05/2027 5040275 - 05/2027 5040276 - 05/2027 5040277 - 05/2027 5040278 - 05/2027 5040279 - 05/2027 5050053 - 6/2027 5050054 - 6/2027 5050055 - 6/2027 5050056 - 6/2027 5060069 - 07/2027 5060070 - 07/2027 5060071 - 07/2027 5060072 - 07/2027 5060073 - 07/2027 5060074 - 07/2027 5060075 - 07/2027 5060076 - 07/2027 5060077 - 07/2027 5060078 - 07/2027 5060079 - 07/2027 5060080 - 07/2027 5080084 - 9/2027 5080085 - 9/2027 5080086 - 9/2027 5090107 - 10/2027 5090108 - 10/2027 5090109 - 10/2027 5090113 - 10/2027 5090114 - 10/2027 5090115 - 10/2027 5090116 - 10/2027 5090117 - 10/2027 5090118 - 10/2027 5100039 - 11/2027 5100048 - 11/2027

TypeCode / valueContext
UPC860012161720al with an 8oz. glass of water or as directed by your health professional; UPC: 8 60012 16172 0

Recall details

Recall number
H-0546-2026
Event ID
98433
FDA status
Terminated
Initiated
Feb 13, 2026
Reported
Mar 18, 2026
Classified
Mar 9, 2026
Terminated
Aug 13, 2026
Quantity
1,224,208 units
Location
New York, NY, United States
Initiation type
Voluntary: Firm initiated
Notification
Press Release

Where it was distributed

Nationwide in the United States, including American Samoa, Northern Mariana Islands, Puerto Rico, and Virgin Islands. International distribution to consumers in: Algeria, Anguilla, Australia, Austria, Bahrain, Belgium, Bosnia and Herzegovina, Brazil, Brunei, Bulgaria, Canada, Chile, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Djibouti, Dominican Republic, Egypt, Estonia, Faroe Islands, Finland, France, French Polynesia, Georgia, Germany, Gibraltar, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Ireland, Israel, Italy, Japan, Jordan, Kuwait, Latvia, Lithuania, Luxembourg, Malaysia, Malta, Marshall Islands, Mexico, Nauru, New Zealand, Netherlands, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Suriname, Sweden, Switzerland, Taiwan, Thailand, Trinidad and Tobago, Turkey, United Arab Emirates, United Kingdom, Venezuela, and Zimbabwe.

FDA source record · H-0546-2026

Data updated September 16, 2026. View official FDA data ↗

A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.